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The circadian clock generates biological rhythms
of metabolic and physiological processes, including
the sleep-wake cycle. We previously identified a
missense mutation in the flavin adenine dinucleotide
(FAD) binding pocket of CRYPTOCHROME2 (CRY2),
a clock protein that causes human advanced sleep
phase. This prompted us to examine the role of
FAD as a mediator of the clock and metabolism.
FAD stabilized CRY proteins, leading to increased
protein levels. In contrast, knockdown of Riboflavin
kinase (Rfk), an FAD biosynthetic enzyme, enhanced
CRY degradation. RFK protein levels and FAD con-
centrations oscillate in the nucleus, suggesting that
they are subject to circadian control. Knockdown of
Rfk combined with a riboflavin-deficient diet altered
the CRY levels in mouse liver and the expression
profiles of clock and clock-controlled genes (espe-
cially those related to metabolism including glucose
homeostasis). We conclude that light-independent
mechanisms of FAD regulate CRY and contribute
to proper circadian oscillation of metabolic genes in
mammals.
INTRODUCTION
Circadian rhythms are observed in organisms across the phylo-
genetic spectrum and are recognized in many biological func-
tions from the molecular level through behavior (Schibler and
Sassone-Corsi, 2002). Rhythms with approximately 24 hr peri-
odicity are governed by the internal time-keeping system, the
circadian clock. At its most basic level, the cell-autonomous
circadian clock is constituted by a transcriptional/translational
negative feedback loop, in which activators (CLOCK/BMAL1)
and repressors (PERIOD1–3 [PER1–3]/CRYPTOCHROME1–2
[CRY1–2]) are coordinately regulated (Hardin and Panda, 2013;
Reppert and Weaver, 2002). We have shown that mutations in
some of the core clock genes (PER2, PER3, Casein kinase Id,
CRY2, DEC2) affect the timing of sleep-wake behavior or sleepC
This is an open access article under the CC BY-Nduration in humans (He et al., 2009; Hirano et al., 2016b; Jones
et al., 1999; Toh et al., 2001; Xu et al., 2005, 2007; Zhang
et al., 2016). Gene targeting or mutations of the clock genes in
rodent models cause circadian phenotypes but also, in some
cases, lead to metabolic dysfunction (Doi et al., 2010; Turek
et al., 2005; Marcheva et al., 2010; Rudic et al., 2004; Shimba
et al., 2011).
The circadian clock is present inmany peripheral tissues, play-
ing important roles in local metabolism (Asher and Sassone-
Corsi, 2015; Hirota and Fukada, 2004; Panda and Hogenesch,
2004; Schibler and Sassone-Corsi, 2002). It has been widely
accepted that cellular metabolism is under the control of the
circadian clock. Indeed, a majority of metabolites display daily
oscillation of tissue and serum concentrations (Dallmann et al.,
2012; Eckel-Mahan et al., 2012; Fustin et al., 2012; Hatori
et al., 2012). These metabolites then feed back to the circadian
clock by modulating enzymatic activity. Recent studies demon-
strate that redox homeostasis is interconnected with the circa-
dian clock. Cellular redox state represented by the relative ratio
of flavin adenine dinucleotide (FAD) (oxidized)/NADPH (reduced)
oscillates in the rodent suprachiasmatic nucleus (SCN) where
the master clock resides (Wang et al., 2012). In mouse liver,
circadian rhythmicity of oxidative function of mitochondria is
observed (Kil et al., 2015; Peek et al., 2013). Furthermore, it
was demonstrated that even without a functional transcrip-
tional/translational negative feedback loop, the circadian oscilla-
tion of the redox state persists in peripheral clocks of various
organisms (Edgar et al., 2012; O’Neill and Reddy, 2011; O’Neill
et al., 2011). The involvement of NAD+ in circadian regulation
has been well characterized (Berger and Sassone-Corsi, 2016;
Rutter et al., 2001). The concentration of NAD+ and a rate-limiting
enzyme of the biosynthetic pathway of NAD+, nicotinamide
phosphoribosyltransferase (NAMPT), cycle in a circadian
manner (Nakahata et al., 2009; Ramsey et al., 2009). NAD+ is a
classic cofactor critical for enzymatic activity of SIRT1 (NAD+-
dependent histone deacetylase) in various species (Blander
andGuarente, 2004; Imai et al., 2000; Landry et al., 2000; Rosen-
berg and Parkhurst, 2002; Tanny et al., 1999). Thus, SIRT1 activ-
ity is directed rhythmically by NAD+, resulting in modulation
of circadian transcription (Nakahata et al., 2008). In parallel,
another group reported that SIRT1-mediated deacetylation of
PER2 protein leads to its stabilization (Asher et al., 2008).ell Reports 19, 255–266, April 11, 2017 ª 2017 The Author(s). 255
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. FAD Stabilizes CRY Protein
(A) Effect of FAD onCRY1 and CRY2 protein levels in HEK293 total cell lysates. Forty-two hours after transfection, HEK293 cells were treated with 100 mMFAD for
6 hr. Data are shown as means with SEM (n = 3, *p < 0.05 by Student’s t test).
(B) Degradation assay of endogenous CRY1 and CRY2 protein in NIH 3T3 cells. The cells were pre-treated with 100 mMFAD (or PBS as a control) for 6 hr and then
treated with 100 mg/mL cycloheximide (CHX) and/or 100 mM FAD. Cells were fractionated, and nuclear extracts were used for western blotting analysis. CRY
protein levels at the starting point (t = 0 hr) were normalized to 1. Data are shown as means with SEM.
(C) Degradation assay ofWT-CRY2 and A260T-CRY2 protein in HEK293 cells. Forty-two hours after transfection, HEK293 cells were pre-treated with FAD for 6 hr
and then treated with 100 mg/mL CHX and/or 100 mMFAD. Cells were fractionated. CRY protein levels in the nuclear fraction at t = 0 hr were normalized to 1. Data
are shown as means with SEM (n = 3). Significance (p < 0.05) was determined by two-way ANOVA.
(legend continued on next page)
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Compared to NAD+, the physiological importance of FAD has
been ignored especially in the mammalian circadian clock. The
major function of FAD is as a co-factor of flavoprotein catalyzing
metabolic reactions (Powers, 2003). By switching its redox state
(FAD#FADH2), an electron is transferred to or from the flavopro-
tein, thus modifying its activity. FAD also acts as a chromophore
of photosensing proteins including CRY in plants andDrosophila
(Ozt€urk et al., 2007). In plants and flies, FAD bound to CRY pro-
tein detects blue light and contributes to signal transduction
pathways generating responses to light signals. In the mamma-
lian molecular clock, CRY1 and CRY2 possess transcriptional
repressor activity (Kume et al., 1999). Knockout of Cry1 and
Cry2 in mice leads to behavioral rhythms being completely abol-
ished (van der Horst et al., 1999; Vitaterna et al., 1999). Thus,
the light-independent function of CRYs has been highlighted.
We recently showed that a missense mutation in CRY2 causing
amino acid conversion from Ala260 to Thr is responsible for
familial advanced sleep phase (FASP) (Hirano et al., 2016b),
which is a sleep trait characterized by early sleep andwake times
(Jones et al., 1999). The Ala260 residue resides in the FAD
binding pocket of CRY2 (Hitomi et al., 2009). FBXL3 (a CRY2
E3 ubiquitin ligase) binds competitively to the same pocket
and promotes ubiquitylation of CRY proteins (Xing et al., 2013).
The mouse model harboring the human CRY2 FASP mutation
(A260T) recapitulated the human phenotype of advanced activity
onset and offset. Although we found that these mutant mice
exhibit altered light entrainment, whether this is a result of direct
light sensing remains unclear (Hirano et al., 2016b). Thus, our
study of the human mutation suggested that FAD may be a
key molecule in the circadian clock through CRY regulation
in vivo.
Here, we demonstrate that FAD stabilizes CRY proteins. A
FAD synthetic enzyme (riboflavin kinase) oscillates in the nu-
cleus, resulting in rhythmic FAD levels. In vivo knockdown of
Rfk, Riboflavin (vitamin B2) kinase essential for FAD synthesis,
altered the expression rhythms of CRY1, CRY2, and PER1.
Expression levels of some metabolic genes were also affected
by Rfk knockdown. These data demonstrate that cycling of
cellular FAD ensures the proper oscillation of CRY expression
and contributes to the overall regulation of cellular metabolism.
RESULTS
FAD Stabilizes CRY1 and CRY2
Previously, we demonstrated that FAD increased CRY2 protein
levels in cell culture (Hirano et al., 2016b). We predicted that(D) CRY and RFK expression in NIH 3T3 cells transfectedwithRfk siRNAs. Overex
by western blotting (n = 3, *p < 0.05 by Dunnett’s test).
(E) CRY1 and CRY2 expression in NIH 3T3 cells stably expressing Rfk shRNAs (
(F) CRY1 expression in NIH 3T3 cells transfected with Flad1 siRNAs (n = 3, *p <
(G) Degradation assay of CRY1 and CRY2 protein in Rfk knockdown cells. NIH 3T3
hours after transfection, the cells were treated with 100 mg/mL CHX. Statistical
hoc test).
(H) Degradation assay of endogenous CRY1 and CRY2 protein in NIH 3T3 cells sta
by two-way ANOVA followed by post hoc test).
(I) FBXL3 competition assay. FLAG-CRY1-HA-FBXL3 or Myc-CRY2-FLAG-FBX
antibody. FAD was added to CRY-FBXL3 complexes and incubated at 4C for 2the effect of FAD on protein levels is conserved in CRY1 and 2
since the amino acid sequence of the FAD binding domain is
well conserved. Similar to CRY2, treatment of cultured cells
with FAD increased CRY1 (Figure 1A). A cycloheximide chase
experiment suggested that the protein stability of endogenous
CRY1 and CRY2 is also increased by FAD treatment in the nu-
cleus, although they did not reach statistical significance (Fig-
ure 1B). CRY2 carrying the A260T mutation in the FAD binding
pocket was less stable versus wild-type (WT) CRY2 in the nu-
cleus (Figure 1C), as previously shown (Hirano et al., 2016b).
Of note, mutant CRY2was not stabilized by FAD treatment, while
WT-CRY2 was (Figure 1C). This indicated that proper binding of
FAD to CRY is needed for the stabilization.
FAD synthesis is a two-step reaction. Riboflavin (vitamin B2), a
precursor of FAD, is first phosphorylated by Riboflavin kinase
(RFK) and converted to flavin mononucleotide (FMN). FMN is
then adenylated by FAD synthase (FADS, encoded by Flad1
gene) to form FAD. RFK is thought to be the rate-limiting
enzyme of the FAD biosynthetic pathway (Kohlmeier, 2003).
We first knocked down the Rfk gene using small interfering
RNAs (siRNAs) in NIH 3T3 cells to examine the effect of reduced
FAD levels on CRY proteins. Rfk knockdown decreased RFK
protein levels as expected. In addition, CRY2 (Figure 1D, upper)
and CRY1 (Figure 1D, bottom) protein levels were also reduced
by Rfk knockdown. Cells stably expressing small hairpin RNA
(shRNA) targeting Rfk showed decreased endogenous CRY1
and CRY2 levels (Figure 1E). Similarly, reduction of CRY1 was
observed by knockdown of the Flad1 gene, supporting the effect
of FAD deficiency (Figure 1F). Moreover, the degradation of
CRY1 andCRY2was enhanced in NIH 3T3 cells either transiently
transfected with siRNAs (Figure 1G) or stably expressing shRNA
for Rfk (Figure 1H). These results revealed that reduced FAD
can promote the degradation of CRY1/2, leading to reduced
protein levels.
Structural studies suggested that FAD interferes with the func-
tion of FBXL3 by competing with FBXL3 for binding to CRY2 (via
the FAD binding pocket) (Nangle et al., 2013; Xing et al., 2013).
We and another group previously showed that FAD competi-
tively released CRY2 from CRY2-FBXL3 complex in vitro (Hirano
et al., 2016b; Xing et al., 2013). We also found that this compet-
itive function of FAD is significantly reduced by the CRY2 A260T
mutation (Hirano et al., 2016b). Similarly, CRY1 is also released
from CRY1-FBXL3 complexes by the presence of FAD in vitro
in a dose-dependent manner (Figure 1I). Together, these results
indicated that FAD competes with FBXL3 and increases stability
of both CRY1 and CRY2 in cultured cells.pressed FLAG-CRY2, endogenous CRY1 and RFK protein levels were analyzed
n = 3, *p < 0.05 by Dunnett’s test).
0.05 by Student’s t test).
cells were transfected with Rfk siRNA and CRY expression vectors. Forty-two
significance (*p < 0.05) was determined by two-way ANOVA followed by post
bly expressing Rfk shRNAs. Statistical significance (*p < 0.05) was determined
L3 complexes expressed in HEK293 cells were purified using HA or FLAG
hr in vitro.
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Figure 2. Rhythmic Expression of Components of the FAD Synthetic Pathway
(A) Temporal expression profiles of Per1 (positive control), Rfk, and Flad1 in mouse liver. C57BL/6J mice entrained to LD 12:12 were sacrificed every 6 hr. mRNA
levels were normalized to G3pdh.
(B) Temporal expression profiles of RFK in mouse liver in DD. For DD, mice were sacrificed every 4 hr on the second day in DD. Liver was fractionated into nuclear
and cytosolic fractions. Data are shown as means ± SEM (n = 3). Statistical significance (p < 0.05) was determined by one-way ANOVA.
(C) Relative FAD amounts in the mouse liver nucleus. Data are shown as means ± SEM (n = 3).FAD Oscillates in the Nucleus
We then examined the expression rhythms of genes encoding
enzymes critical for FAD biosynthesis. Rfk and Flad1 mRNAs
did not show significant expression rhythms (Figure 2A). On
the other hand, we observed that nuclear RFK protein levels
peaked in the middle of the night (CT18) in constant darkness
(Figure 2B). Consistent with this, the nuclear concentration of
FAD shows clear daily rhythms (Figure 2C) with the peak time
at ZT12. These results suggested that FAD plays a time- and
location-dependent role to regulate CRY stability by competing
with FBXL3, which is supported by the fact that FBXL3 is pre-
dominantly localized in the nucleus (Godinho et al., 2007; Hirano
et al., 2013; Yoo et al., 2013). Indeed, the peak time of FAD
oscillation (around ZT12) coincides with the time when CRY1
and CRY2 protein start accumulating in liver, implying that FAD
contributes to this accumulation.
FAD Affects the Circadian Period in Cell Culture
The stability of CRY1 andCRY2 significantly affects the circadian
period at molecular and behavioral levels (Godinho et al., 2007;
Hirano et al., 2014, 2016a; Ode et al., 2016; Siepka et al.,
2007). Additionally, the FASP mouse model expressing A260T-
CRY2 protein exhibits shorter circadian period of both behavioral
rhythms and cellular rhythms in peripheral tissues (Hirano et al.,
2016b). To examine the effect of FAD on the cellular clock, we
analyzed PER2::LUC bioluminescence rhythms in the presence
of FAD. FAD treatment lengthened the circadian period in a
dose-dependent manner (Figure 3A). This is consistent with258 Cell Reports 19, 255–266, April 11, 2017the previous finding that inhibition of FBXL3 increased CRY pro-
tein stability, thus lengthening the circadian period (Godinho
et al., 2007; Hirota et al., 2008; Siepka et al., 2007). In agreement
with these observations, we found that CRY1 and CRY2 protein
accumulated to higher levels when NIH 3T3 cells were treated
with FAD after being synchronized by dexamethasone (DEX)
(Figure 3B).
Riboflavin Deficiency and In Vivo Knockdown of Rfk Led
to Lower CRY Levels
To investigate the in vivo role of FAD, we analyzed the protein
expression rhythms in liver ofRfk knockdownmice.We prepared
mice by entraining them to light-dark (LD) 12:12 with free access
to normal chow or riboflavin (vitamin B2)-deficient chow. Subse-
quently, mice underwent tail vein injection with an Rfk siRNA to
knock down Rfk in liver (Figure 4A). We found that 2 weeks of ac-
cess to a riboflavin-deficient diet did not cause reduction of CRY
levels, at least at ZT18 (Figure 4B, control). However, when sub-
jected to a riboflavin-deficient diet, knockdown ofRfk decreased
CRY1 and CRY2 at ZT18 (Figure 4B). Knockdown by Rfk siRNA
was successful in mice whether they were maintained on a diet
of normal or riboflavin-deficient chow. Next, we asked how
FAD deficiency affects other clock proteins in constant dark-
ness. Similar to the LD cycle, CRY protein levels were decreased
at CT18. The effect of Rfk knockdown seemed time dependent,
and accumulation of nuclear CRY proteins (from CT6 to CT18)
was slow in the knockdown mice. Of note, chronic FAD treat-
ment also disrupted the expression rhythms of CRY1 and
Figure 3. Cellular Rhythms of PER2::LUC MEFs Treated with FAD
(A) Representative rhythms of PER2::LUC bioluminescence in MEFs from Per2Luc knockin mice. Cellular rhythms of MEFs were synchronized by 100 nM DEX.
Media was replaced by a recording media containing 10100 mM FAD (or PBS) and 100 mM luciferin for recording of bioluminescence. Period lengths of the
bioluminescence rhythms are shown as means ± SEM (n = 4, *p < 0.05 by Tukey’s test).
(B) NIH 3T3 cells were synchronized by 100 nMDEX.Media was replaced by freshmedia containing 100 mMFAD (or PBS). Total cell lysateswere used for western
blotting analysis. Data are shown as means ± SEM (n = 3, *p < 0.05 by two-way ANOVA followed by post hoc test).CRY2 in NIH 3T3 cells (Figure 3B). Together, these results
suggest a role for FAD in regulating expression rhythms of
CRY. Interestingly, PER1 protein was also decreased by Rfk
knockdown at CT12 and 18 (Figures 4C and 4D). Similar alter-
ations were detected in cell-culture experiments, where knock-
down of Rfk and Flad1 decreased PER1 and CRY1 protein levels
(Figure S1A).
Expression of Clock Genes Is Altered byRfk Knockdown
In addition to the effects of CRY1 and CRY2 in regulating expres-
sion of clock genes, they are also thought to regulate expression
of many metabolism-related genes (Oishi et al., 2003). A recent
chromatin immunoprecipitation sequencing (ChIP-seq) study
indicated that CRY rhythmically occupies not only E-boxes, but
also nuclear receptor response elements to control gene tran-
scription (Koike et al., 2012). In Rfk knockdown mice maintained
on a riboflavin-deficient diet, gene expression was significantly
decreased for Per1 (consistent with reduced PER1 protein levelsseen in liver extracts) and other clock genes (Figures 4D and 4E).
Decreased accumulation of CRY1/2 proteins around CT12–18
and reduction of clock gene expression were also observed by
another siRNA targeting Rfk (Figures S1B and 1C). Among clock
components, we found that Per1 mRNA and protein levels were
significantly affected by FAD depletion. As Per1 is a target gene
of CRY1, we performed a ChIP assay using CRY1 antibody in
the knockdown mice. As shown in the previous ChIP-seq study
(Koike et al., 2012), the CRY1 ChIP signal at the Per1 promoter
E-box is highest at CT0 (Figure S1D). The DNA binding of CRY1
was significantly decreased by Rfk knockdown, suggesting that
FAD depletion altered CRY transcriptional activity.
The Effect of FAD Deficiency on Metabolic Pathways
We next examined the transcript levels of a series of genes
related to metabolism in liver (Figures 5A and S2A). Glucagon
promotes gluconeogenesis, and the expression of glucagon-
inducible genes is inhibited by CRY protein through suppressionCell Reports 19, 255–266, April 11, 2017 259
Figure 4. Effect of Rfk Knockdown on Clock Proteins in Mouse Liver
(A) Experimental scheme for in vivo knockdown of the Rfk gene. Mice were fed normal or riboflavin-deficient chow for 2 weeks. Rfk siRNA or control siRNA was
injected into mice via the tail vein at ZT10–12. Three days or 6 days after the injection, mice were sacrificed to collect liver tissues.
(B) Nuclear protein levels of CRY1, CRY2, and RFK at ZT18. TATA-binding protein (TBP) was used as a nuclear marker.
(C) Nuclear protein expression of PER1, CLOCK, CRY1, and CRY2 at indicated CT in DD.
(legend continued on next page)
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of cyclic AMP (cAMP) signaling (Zhang et al., 2010). A small
synthetic compound (KL001) that stabilizes CRY was shown to
reduce the response to glucagon. Thus, KL001 lowered the in-
duction of major glucagon targets such as glucose-6-phospha-
tase (G6pc) and phosphoenolpryvate carboxykinase 1, cytosolic
(Pck1) genes in mouse hepatocytes (Hirota et al., 2008). We
found that G6pc expression was increased by Rfk knockdown
at CT6 and 12 in liver extracts of mice on a riboflavin-free diet
(Figure 5A), while there was no effect on Pck1. These data sug-
gest that gluconeogenesis is disturbed by depletion of cellular
FAD. In addition, we found that blood glucose concentrations
showed a tendency to increase and that glucose levels in liver
were significantly increased by Rfk knockdown (Figure 5B). In
HepG2 cells (derived from a liver hepatocellular carcinoma),
FAD treatment decreased while Rfk knockdown increased the
oxygen consumption rate (OCR) (Figure 5C), an indicator of
cellular metabolism. Enhanced OCR generally represents reduc-
tion of glycolysis. Consistent with this, FAD treatment increased
the extracellular acidification rate (ECAR), an indicator of glycol-
ysis (Figure 5D). On the other hand, Rfk knockdown reduced the
ECAR, indicating that FAD deficiency decreased glycolysis and
increased gluconeogenesis, which is promoted by G6pc. Of
note, these effects were cancelled by knockdown of CRY1 and
CRY2. As shown in Figure 5C, knockdown of Rfk increased
OCR in HepG2 cells (Figure 5E, left). Knockdown of both
CRY1/2 and Rfk decreased OCR rather than further elevating it
(Figure 5E, right), suggesting an additional regulatory pathway(s)
is involved. On the other hand, CRY1/2 knockdown attenuated
the effect of Rfk knockdown on ECAR (Figure 5F). A previous
study also showed that knockout of Cry1 and Cry2 decreased
glycolysis in liver (Peek et al., 2013), supporting the critical role
of CRY in glycolysis. Besides glucose homeostasis, some meta-
bolic genes such as Pparg (regulator of hepatic steatosis), Acs1,
and Scd1 (regulators of sterol metabolism) were also modulated
by the knockdown, suggesting a more global effect of FAD loss
on cellular metabolism (Figures 5G and S2B). Taken together,
our study emphasizes that cycling FAD feeds back to the
circadian clock through its regulation of CRY stability, thereby
controlling metabolic pathways (Figure 5H).
DISCUSSION
In the present study, we demonstrate that FAD levels are
controlled in a circadian manner (Figure 2C). The peak timing
of FAD rhythms was around ZT12 when CRY1 and CRY2 pro-
teins start to accumulate in mouse liver (Lee et al., 2001). FAD
deficiency affected CRY stability and accumulation in the circa-
dian cycle (Figures 1 and 4C), suggesting that FAD-mediated
stabilization contributes to the nuclear accumulation of CRY.
We also found that RFK protein levels (the rate-limiting FAD
biosynthetic enzyme) in the nucleus show circadian changes
(Figure 2B). However, the mechanisms for rhythmic expression(D) Quantification of PER1, CLOCK, CRY1, and CRY2 protein levels shown in (C
Data in (C) and (D) are shown as means ± SEM (n = 3, *p < 0.05 by two-way AN
(E) mRNA levels of indicated clock genes in mouse liver at specified CT in DD. mR
*p < 0.05 by two-way ANOVA followed by post hoc test).of the riboflavin transporters or enzymatic activity of RFK and
FADS remain elusive. Moreover, redox homeostasis (ratio of
reduced to oxidative forms of FAD) plays a critical role in the
proper maintenance of cellular physiology, and recent findings
revealed that daily rhythms of redox state is an integral part of
circadian regulation (Edgar et al., 2012; O’Neill et al., 2011;
Peek et al., 2013; Wang et al., 2012). Thus, in addition to biosyn-
thesis, the cellular redox state can contribute to the oscillation
of FAD.
The expression of clock genes and clock-controlled genes
was disturbed by Rfk knockdown (Figures 4D, 4E, 5A, and 5G).
Interestingly, genes displaying significantly altered expression
also have high ChIP scores in a comprehensive CRY1 and
CRY2 ChIP-seq study (Koike et al., 2012), suggesting that they
are direct targets of CRY. For example, ChIP scores in the
G6pc promoter were ranked 111th (for CRY1) and 20th (for
CRY2) among all genes (>10,000) with specific ChIP signals.
On the other hand, Pck1, another target of glucagon, was ranked
852nd (CRY1) and 1,658th (CRY2) by ChIP score (Koike et al.,
2012) and showed no change with Rfk knockdown (Figure 5A).
Furthermore, we found that CRY1/2 knockdown reversed or
attenuated the effect of Rfk silencing in OCR and ECAR assays,
suggesting the involvement of CRY-FAD regulation in glucose
metabolism (Figures 5E and 5F). Congruent with these data,
metabolomics analysis revealed altered glucose metabolism
under FAD treatment in HepG2 cells (Figure S3). However, to
ensure that this is relevant in vivo, further investigation using
Cry1/2 knockout mice or mice harboring mutations in the FAD
binding domain of CRY1 and CRY2 will be needed. Per1 also
scored the highest in the previous ChIP study of CRYs and,
in our studies, showed significant alterations in both mRNA
expression and protein levels. We observed that Rfk knockdown
reduced DNA binding of CRY1 to a target sequence of the Per1
promoter (Figure S1D). However the reduction of Per1 expres-
sion by Rfk knockdown argues that its regulation is even more
complex. Previously, we and another group reported that
mutation at the FAD binding site of CRY altered CRY repressor
activity (Hirano et al., 2016b; Hitomi et al., 2009). Therefore,
FAD deficiency may affect CRY repressor activity, which cannot
be detected by the ChIP assay.
FAD is a co-factor of CRY in various species (Lin and Todo,
2005). In plants and flies, CRY harboring FAD detects blue light
and contributes to the biological response to light by changing
protein conformation. In plants, Arabidopsis CRY regulates
development and growth in response to light. Drosophila CRY
is a circadian photosensor contributing to clock resetting in
response to light. Furthermore, dCRY acts as a light-dependent
magnetosensor and knockout results in loss of magnetosensa-
tion (Gegear et al., 2008, 2010). Interestingly, human CRY2 can
rescue the light-dependent magnetosensation phenotype of
dCry-deficient flies (Foley et al., 2011). Whether CRY2 is actually
involved in magnetoreception in mammalian physiology is).
OVA followed by post hoc test).
NA levels were normalized to G3pdh. Data are shown as means ± SEM (n = 3,
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Figure 5. Rfk Knockdown Results in Altered Expression of Genes in Metabolic Pathways
(A) mRNA levels of G6pc and Pck in mouse liver. mRNA levels were normalized to Tbp. Data are shown as means ± SEM (n = 3, *p < 0.05 by two-way
ANOVA).
(B) Glucose levels in blood serum (left) and liver (right) at CT12. Data are shown as means ± SEM (n = 3, *p < 0.05 by Student’s t test).
(C) OCR assay in HepG2 cells. Cells were transfected with siRNA of Rfk or treated with 100 mM FAD for 24 hr. Data are shown as means ± SEM (n = 6). Statistical
significance was determined by two-way ANOVA.
(D) ECAR assay in HepG2 cells. Cells were transfected with Rfk siRNA or treated with 100 mM FAD for 24 hr before recording fluorescence of a glycolysis probe.
Data are shown as means ± SEM (n = 5 for FAD treatment, n = 9 for Rfk knockdown). Statistical significance was determined by two-way ANOVA.
(E) OCR assay in HepG2 cells transfected with siRNA of Rfk and/or CRY1/2. Data are shown as means ± SEM (n = 9).
(F) ECAR assay in HepG2 cells transfected with siRNA of Rfk and/or CRY1/2. Data are shown as means ± SEM (n = 9).
(legend continued on next page)
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unknown. On the other hand, mammalian CRYs have acquired
repressor activity of transcription and are considered core com-
ponents in the circadian clock. CRY repressor activity is light in-
dependent (Griffin et al., 1999), and the central clock (SCN) does
not detect light directly. Thus, the link between FAD and the
mammalian circadian clock in the physiological context was un-
clear. A recent report revealed that LSD1, a lysine-specific FAD-
dependent histone demethylase, regulates the light resetting of
the circadian clock through protein kinase C (PKC)-a-mediated
phosphorylation of LSD1 (Nam et al., 2014). Phosphorylated
LSD1 (at Ser112) interacts with CLOCK/BMAL1 complexes
and modulates E-box-mediated gene expression. Knockout of
Lsd1 or knockin of a mutation at the phosphorylation site of
LSD1 (Ser112 to Ala) led to decreased amplitude of gene expres-
sion in mouse embryonic fibroblasts and behavioral rhythms in
mice. However, histone demethylation was intact in these Lsd1
mutant mice. Thus, it is likely that the role of LSD1 in circadian
phenotypes is independent of FAD. Furthermore, the circadian
periods of these Lsd1 mutants remain indistinguishable from
normal mice. Here, we found that FAD treatment indeed modu-
lates the circadian period (Figure 3A). The data presented in this
study therefore demonstrate that FAD contributes to circadian
rhythmicity by binding to CRYs and that a deficiency of FAD
causes dysregulations of metabolism.
Riboflavin (vitamin B2) is an essential nutrient for mammals.
Because mammals are unable to synthesize it, we depend on di-
etary intake of riboflavin (Powers, 2003). Deficiency of riboflavin
causes abnormal development, neurodegeneration, cardiovas-
cular disease, alterations of DNA damage repair, and cancer
(Powers, 2003). Although the effect of riboflavin deficiency may
act through different pathways, some of these effects may be
mediated through disturbance of CRY protein levels and altered
circadian regulation. Indeed, CRY proteins are highly associated
with cancer development and DNA damage (Lee et al., 2013;
Ozturk et al., 2009; Papp et al., 2015). In the present study, we
found that administration or deletion of FAD altered glucose
metabolism through CRYs (Figure 5), indicating a significant
role for the FAD-CRY pathway in normal physiology.
EXPERIMENTAL PROCEDURES
Mice
All experimental protocols were conducted according to USNational Institutes
of Health guidelines for animal research and were approved by the Institutional
Animal Care and Use Committee at the University of California, San Francisco.
Mice were kept in cages with free access to food and water. Riboflavin-defi-
cient chow was purchased from Research Diets.
Cell Culture and Constructs
HEK293 cells, NIH 3T3 cells, and HepG2 cells were purchased from ATTC.
Authentication of the cell lines was performed by ATCC according to their pro-
tocol. Cultures were tested for mycoplasma contamination, and all cell lines
used for experiments were mycoplasma free. HEK293 cells and NIH 3T3 cells
were cultured in DMEM (Corning) containing 10% fetal bovine serum (FBS) and(G) mRNA levels of indicated metabolism-relevant genes in mouse liver. mRNA le
by two-way ANOVA).
(H) Proposed model of CRY regulation by FAD. The classical clock generates gen
FAD and NAD+. FAD binding to CRY prevents FBXL3-mediated CRY degradat
expression rhythms and amplitudes, which regulate the gene expression rhythm100 U/mL penicillin-streptomycin (Thermo Fisher Scientific) and maintained
by standard methods. HepG2 cells were maintained in MEM containing 10%
FBS, non-essential amino acids, and 1 mM sodium pyruvate. Mouse embry-
onic fibroblasts (MEFs) were prepared from E12.5 embryos of Per2luc knockin
mice (Yoo et al., 2004). After removing the head, paws, and internal organs,
embryos were chopped and incubated in 0.25% trypsin in PBS for 24 hr at
4C. After incubation for 30 min at 37C in 0.25% trypsin in PBS, cells were
dissociated by pipetting in DMEM. The supernatant was cultured in a cell-cul-
ture dish with DMEM and maintained by standard methods. Cells were trans-
fected with Lipofectamine 3000 transfection reagent (Thermo Fisher Scientific)
according to manufacturer’s protocol. DNA constructs used for transfections
are listed in Supplemental Experimental Procedures (Hirano et al., 2016b).
Bioluminescence Rhythms in Cell Culture
Cellular rhythms were synchronized by treatment with 100 nM DEX for 2 hr.
Media was changed to the recording media: phenol-red free DMEM (Sigma-
Aldrich) containing 10 mM HEPES (pH 7.0), 3.5 g/L D-glucose, and 0.1 mM
luciferin potassium salt (Thermo Fisher Scientific). Bioluminescence was
continuously recorded in a LumiCycle 32 instrument (Actimetrics). Biolumines-
cence was detrended by subtracting 24 hr average of bioluminescence using
the LumiCycle analysis software to calculated periods.
Expression Profiles of Proteins and Genes
C57BL/6J male mice (10 weeks old) were entrained to LD 12:12 for at least
10 days. For expression rhythms of RFK in DD, mice were sacrificed every
4 hr in dim red light on the second day of DD. For LD, mice were sacrificed
every 6 hr. Liver tissues were collected, followed by nuclear extraction (Yoshi-
tane et al., 2009) and mRNA extraction.
Nuclear and Cytosolic Fractionation of Cells
Cells were resuspended in the lysis buffer (10 mM HEPES-potassium hydrox-
ide [KOH] [pH 7.8 at 4C], 10 mM KCl, 0.1 mM EDTA, and 0.2% NP-40) con-
taining 1 mM DTT and protease inhibitor (Thermo Fisher Scientific) and incu-
bated for 10 min on ice. Cell membranes were disrupted by vortexing twice
for 15 s, followed by centrifugation for 10min at 20,0003 g. The pellet (nuclear
fraction) was washed with the lysis buffer without NP-40 and dissolved in SDS
sample buffer (62.5mMTris-HCl [pH 6.8], 50mMDTT, 2%SDS, 10%glycerol).
Western Blotting
For whole-cell extracts, HEK293 cells were lysed in SDS sample buffer
(62.5 mM Tris-HCl [pH 6.8], 50 mM DTT, 2% SDS, and 10% glycerol). Prepa-
ration of the cytosolic and the nuclear fractions of mouse liver was performed
as previously described (Yoshitane et al., 2009). Protein samples were sepa-
rated by SDS-PAGE. Tissues were transferred to polyvinylidene fluoride
(PVDF) membranes (Millipore) with blocking in T-TBS (50 mM Tris-HCl
[pH 7.4], 137mMNaCl, and 0.1% Tween 20) containing 1% skimmilk. Primary
antibodies were reacted in the blocking solution at 4C overnight. Then, sec-
ondary antibodies were reacted in the blocking solution at room temperature
(RT) for 2 hr. Proteins were detected with the Western Lightning Plus ECL
(PerkinElmer). Band intensities were determined using ImageJ software.
b-actin was used as a loading control for total cell lysates, and TATA-binding
protein (TBP) was used as the nuclear marker. Proteins were detected with the
following antibodies: anti-cMyc 9E10 (Santa Cruz Biotechnology, sc-40), anti-
FLAG M2 (Sigma-Aldrich, F1804), anti-HA Y11 (Santa Cruz Biotechnology,
sc-805-G), anti-b-actin (Abcam, AC-15), anti-LMNB1 (Abcam, ab16048),
anti-TBP (Santa Cruz), anti-hPER1 (Thermo Fisher Scientific, PA1-524), anti-
mPER2 (Alpha Diagnostic International, PER-21A), anti-CLOCK (MBL Inter-
national, D333-3), anti-CRY1 (MBL International, PM081), and anti-CRY2
(MBL International, PM082). Secondary antibodies used were goat anti-
mouse immunoglobulin G horseradish peroxidase (IgG-HRP) (Santa Cruzvels were normalized to Tbp. Data are shown as means ± SEM (n = 3, *p < 0.05
e expression rhythms including Rfk and Nampt, which rhythmically synthesize
ion, leading to stabilization. Time-dependent FAD synthesis modulates CRY
s of important genes for metabolism.
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Biotechnology, sc-2005), goat anti-rabbit IgG-HRP (Santa Cruz Biotech-
nology, sc-2006), and goat anti-guinea pig IgG-HRP (Santa Cruz Biotech-
nology, sc2438).
Real-Time qPCR
Total RNAwas extracted by TRIzol reagent (Thermo Fisher Scientific) from liver
samples and purified by RNeasy Mini kit (QIAGEN). cDNA was synthesized
from 1.5 mg RNA by GoScript (Promega) using dT15 primer. Quantification of
mRNA was performed with GoTaq Real-Time qPCR Kits (Promega) using
gene-specific primers (Table S1). mRNA levels were normalized by mouse
Gapdh or Tbp levels.
FAD Concentration
FAD was measured with an FAD assay kit (Sigma-Aldrich) following the man-
ufacturer’s protocol. Briefly, the nuclear extract was added to 2 vol of 8% (w/w)
perchloric acid (PCA), followed by vortexing the mixture for 30 s. The lysate
was centrifuged for 10 min at 1,500 3 g, and the supernatant was used for
FAD measurements.
FAD Competition Assay
Flavin adenine dinucleotide disodium salt hydrate (FAD, Sigma-Aldrich) was
diluted in PBS to make a 100 mM stock solution. HEK293 cells were trans-
fected with plasmid vectors for CRY (FLAG-CRY1 or CRY2-Myc-His) and
FBXL3 (HA-FBXL3 or FLAG-FBXL3). Forty-two hours after transfection, the
cells were treated with 10 mMMG132 (Calbiochem) for 6 hr. CRY-FBXL3 com-
plex was purified with anti-FLAG M2 affinity gel (Sigma-Aldrich) or HA anti-
body. FAD was incubated with CRY1-FBXL3 complex binding to anti-FLAG
M2 affinity gel or protein G Sepharose (GE Healthcare) in 40 mL PBS for 2 hr
on ice. After centrifugation, the supernatant was collected as the ‘‘released
CRY’’ sample. CRY still binding to FBXL3 was eluted by adding SDS sample
buffer.
Tail Vein Injection of siRNA
siRNA for Rfk was purchased from Thermo Fisher Scientific (siRNA#1: cata-
log # S79629; siRNA#2: catalog # S79628). siRNA solution for the injection
was prepared according to the manual of Invivofectamine 3.0 (Thermo Fisher
Scientific). BALB/c male mice (8 weeks old) were fed a normal diet or
riboflavin-free diet for 2 weeks. Mice (10 weeks old at the injection) were
anesthetized with isoflurane during the procedure, and siRNA targeting Rfk
or equivalent amounts of control siRNA (3 mol/mice each siRNA) were in-
jected through the tail vein using a 28G syringe. Injections were performed
at ZT10–12.
Glucose Concentration
Four days after the injection of siRNAs, blood was collected from mouse tail
veins. Blood was incubated for 60 min at 37C and centrifuged at 3,000 rpm
for 20 min. The supernatant was collected and used for a glucose oxidation
assay (Sigma-Aldrich). For glucose concentration in liver lysate, proteins
were removed by PCA precipitation. One-third volume of 4 M PCA was added
to total liver lysate, followed by incubation on ice for 5 min. After centrifugation
at 13,0003 g for 2 min, the supernatant was collected. Ice-cold 2 M KOH was
added to titrate pH to7.0. Samples were centrifuged at 13,0003 g for 15min
at 4C, and the supernatant was used for the glucose oxidation assay (Sigma-
Aldrich).
OCR and ECAR
HepG2 cells were cultured in 96-well plates and transfected with indicated
siRNAs. Twenty-four hours after the transfection, cell-culture media were re-
placed by media containing the OCR fluorescence probe (Abcam, OCR kit)
and cultured for 24 hr. Media was changed to recording media: phenol-red-
free DMEM (Sigma-Aldrich) containing 10 mM HEPES (pH 7.0), 3.5 g/L
D-glucose, and 10% FBS. Florescence was continuously measured every
2.5 or 5 min with a Synergy H4 Hybrid Multi-Mode Microplate Reader (BioTek).
For ECAR, transfected cells were cultured for 48 hr, and culture media was
changed to glycolysis buffer containing probe (Abcam, ECAR kit). Florescence
was measured every 1.5 min using a Synergy H4 Hybrid Multi-Mode Micro-
plate Reader (BioTek).264 Cell Reports 19, 255–266, April 11, 2017Statistical Analysis
All error bars in the figures represent SEM. No statistical analysis was used to
predetermine the sample sizes. Experiments were not randomized and were
not analyzed blindly. Data were statistically analyzed using R software and
Prism7. To assess statistical significance, data were obtained from three or
more independent experiments. Two-tailed paired Student’s t test, Tukey’s
test, one-way ANOVA, or two-way ANOVA followed by Sidak test (as post
hoc test) was used. p values <0.05 were considered to represent a statistically
significant difference.
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